FineMark National Bank & Trust’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$20.8M Buy
100,355
+1,042
+1% +$206K 0.65% 32
2025
Q3
$18.4M Sell
99,313
-2,704
-3% -$463K 0.6% 38
2025
Q2
$15.6M Buy
102,017
+15
+0% +$2.31K 0.53% 50
2025
Q1
$16.9M Sell
102,002
-2,607
-2% -$408K 0.62% 41
2024
Q4
$15.1M Sell
104,609
-3,639
-3% -$564K 0.53% 55
2024
Q3
$17.5M Buy
108,248
+8,633
+9% +$1.38M 0.61% 44
2024
Q2
$14.6M Sell
99,615
-1,315
-1% -$196K 0.54% 53
2024
Q1
$16M Buy
100,930
+2,554
+3% +$407K 0.59% 43
2023
Q4
$15.4M Sell
98,376
-2,035
-2% -$312K 0.63% 35
2023
Q3
$15.6M Sell
100,411
-1,293
-1% -$213K 0.68% 31
2023
Q2
$16.8M Sell
101,704
-2,294
-2% -$370K 0.69% 35
2023
Q1
$16.1M Sell
103,998
-2,210
-2% -$357K 0.69% 36
2022
Q4
$18.8M Sell
106,208
-943
-0.9% -$163K 0.84% 23
2022
Q3
$17.5M Buy
107,151
+2,093
+2% +$354K 0.84% 22
2022
Q2
$18.6M Buy
105,058
+2,856
+3% +$509K 0.82% 24
2022
Q1
$18.1M Buy
102,202
+1,751
+2% +$298K 0.72% 29
2021
Q4
$17.2M Buy
100,451
+19
+0% +$3.11K 0.65% 33
2021
Q3
$16.2M Sell
100,432
-368
-0.4% -$62.8K 0.69% 31
2021
Q2
$16.6M Buy
100,800
+1,968
+2% +$326K 0.67% 31
2021
Q1
$16.2M Buy
98,832
+1,783
+2% +$289K 0.69% 29
2020
Q4
$15.3M Buy
97,049
+18,411
+23% +$2.72M 0.68% 30
2020
Q3
$11.7M Sell
78,638
-811
-1% -$120K 0.57% 41
2020
Q2
$11.2M Buy
79,449
+297
+0.4% +$43.3K 0.62% 40
2020
Q1
$10.4M Sell
79,152
-1,109
-1% -$157K 0.65% 35
2019
Q4
$11.7M Buy
80,261
+1,482
+2% +$201K 0.59% 44
2019
Q3
$10.2M Sell
78,779
-1,124
-1% -$148K 0.54% 44
2019
Q2
$11.1M Buy
79,903
+3,905
+5% +$541K 0.62% 39
2019
Q1
$10.6M Sell
75,998
-4,760
-6% -$638K 0.62% 38
2018
Q4
$10.4M Buy
80,758
+3,698
+5% +$516K 0.71% 30
2018
Q3
$10.6M Sell
77,060
-13,918
-15% -$1.85M 0.65% 35
2018
Q2
$11M Buy
90,978
+2,090
+2% +$261K 0.67% 34
2018
Q1
$11.4M Buy
88,888
+7,088
+9% +$958K 0.72% 31
2017
Q4
$11.4M Sell
81,800
-6,779
-8% -$944K 0.73% 31
2017
Q3
$11.5M Buy
88,579
+165
+0.2% +$21.9K 0.77% 29
2017
Q2
$11.7M Sell
88,414
-388
-0.4% -$49.5K 0.84% 23
2017
Q1
$11.1M Buy
88,802
+369
+0.4% +$44.1K 0.81% 25
2016
Q4
$10.2M Buy
88,433
+2,612
+3% +$302K 0.82% 23
2016
Q3
$10.1M Sell
85,821
-1,516
-2% -$184K 1.08% 21
2016
Q2
$10.6M Sell
87,337
-2,386
-3% -$271K 1.18% 17
2016
Q1
$9.71M Sell
89,723
-2,401
-3% -$249K 1.14% 22
2015
Q4
$9.46M Sell
92,124
-2,717
-3% -$273K 1.13% 16
2015
Q3
$8.85M Sell
94,841
-11,170
-11% -$1.08M 1.19% 13
2015
Q2
$10.3M Sell
106,011
-1,134
-1% -$114K 1.35% 9
2015
Q1
$10.8M Buy
107,145
+3,839
+4% +$390K 1.47% 8
2014
Q4
$10.8M Buy
103,306
+5,832
+6% +$615K 1.59% 6
2014
Q3
$10.4M Buy
97,474
+1,013
+1% +$105K 1.66% 6
2014
Q2
$10.1M Buy
96,461
+4,081
+4% +$412K 1.7% 6
2014
Q1
$9.07M Buy
92,380
+4,259
+5% +$395K 1.7% 7
2013
Q4
$8.07M Buy
88,121
+2,900
+3% +$267K 1.67% 7
2013
Q3
$7.39M Buy
85,221
+9,122
+12% +$818K 1.83% 6
2013
Q2
$6.53M Buy
+76,099
New +$6.46M 1.97% 6

Other funds holding JNJ

FineMark National Bank & Trust's JNJ Position: Q4 2025 in Review

FineMark National Bank & Trust increased its Johnson & Johnson (JNJ) stake by 1% in Q4 2025, buying an estimated $206K and bringing the position to 100,355 shares worth $20.8M. The position accounts for 0.65% of the portfolio, ranked #32.

FineMark National Bank & Trust first reported a position in JNJ in Q2 2013 and has held it in 51 quarters since. 4,521 funds tracked by Wall St. Rank hold JNJ as of Q4 2025.

  • FineMark National Bank & Trust held 100,355 shares of Johnson & Johnson worth $20.8M as of Q4 2025.
  • FineMark National Bank & Trust bought 1,042 Johnson & Johnson shares in Q4 2025, an estimated $206K.
  • Johnson & Johnson made up 0.65% of FineMark National Bank & Trust's portfolio in Q4 2025, its #32 holding.
  • FineMark National Bank & Trust first reported a position in Johnson & Johnson in Q2 2013 and has held it in 51 quarters since.
  • 4,521 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2025.

Based on FineMark National Bank & Trust's 13F filing for Q4 2025, filed 12 Feb 2026.